Recombinant influenza hemagglutinin HA1 (A/Brisbane/02/2018)(H1N1)
Beta LifeScience
SKU/CAT #: BLIT-1032
Recombinant influenza hemagglutinin HA1 (A/Brisbane/02/2018)(H1N1)
Beta LifeScience
SKU/CAT #: BLIT-1032
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Tag | His |
Host Species | H1N1 |
Background | Influenza (flu) is a contagious respiratory illness caused by influenza viruses. It can cause mild to severe illness. Serious outcomes of flu infection can result in hospitalization or death. |
Description | Recombinant influenza hemagglutinin HA1 HA1(A/Brisbane/02/2018)(H1N1) (aa 18-345; GISAID# EPI1383389) was expressed in HEK293 cell culture and fused with 6xHis tag at C-terminus. |
Source | HEK293 |
AA Sequence | aa 18-345 |
Purity | -‰¥95% |
Formulation | Each vial contains 100 µg of purified protein (1 mg/ml) in PBS. |
Applications | Antibody ELISA; immunogen; WB, Functional analysis, etc. |
Concentration | 1mg/mL |
Usage | For Research Use Only |
Storage | The Recombinant HA1(A/Brisbane/02/2018)(H1N1)virus antigen is stable for a month at 4°C. It should be stored at -80°C from the date of shipment. Please avoid repeated freeze thaw cycles. |